AKR1C2 and esophageal squamous cell carcinoma: As shown in Figure 2C, a high expression of AKR1C2 was correlated to a poorer prognosis in patients with ESCC (P < .0001) and was further confirmed in the validation cohort (P = .04; Figure 2D).